Where the math is defensible.
Long-form research on live enterprise decisions. Publication is selective. Every number traces to a named source. No takes without evidence.
India Adani Group: From Hindenburg to DOJ Indictment, the 2026 Fallout
Two years after the January 24, 2023 Hindenburg Research short report, the Adani Group faces a five count US Department of Justice indictment unsealed in the Eastern District of New York on November 20, 2024, alleging USD 265 million in bribes to Indian state officials. Group market capitalization, ports leverage, banking exposure, and India sovereign perception are all in play.
On November 20, 2024 the US Department of Justice Eastern District of New York unsealed a five count indictment against Gautam Adani, Sagar Adani, Vneet Jaain, and four codefendants, alleging securities fraud, securities fraud conspiracy, wire fraud conspiracy, and Foreign Corrupt Practices Act violations tied to USD 265 million in bribes...
US healthcare private equity rollup at the antitrust inflection: physician practices, hospital chapter 11, and the 2026 refi wall
PE healthcare deal value has settled into the 80 to 100 billion dollar a year band after the 2021 peak, even as Envision and Steward have proven the LBO model can break, and the FTC, DOJ, and a growing list of state attorneys general are now writing rules around physician rollups.
Private equity ownership in US healthcare reached an inflection point between 2023 and 2026. Pitchbook tallied roughly 1,049 PE healthcare deals in 2024 with disclosed value near 115 billion dollars, well below the 2021 peak. KKR backed Envision Healthcare filed for chapter 11 in May 2023, wiping out about 7 billion dollars of equity. Cer...